DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ursodiol (Ursodiol) - Dysmorphism - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dysmorphism (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ursodiol where reactions include dysmorphism. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ursodiol side effects in female

Reported by a individual with unspecified qualification from France on 2012-04-26

Patient: female

Reactions: Maternal Drugs Affecting Foetus, Dysmorphism, Caesarean Section, NO Adverse Event

Drug(s) suspected as cause:
Aspirin
    Dosage: 250 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy

Josacine / 00273602 / (Josamycin Propionate)
    Indication: Foetal Exposure During Pregnancy

Cellcept
    Dosage: 250 mg, bid, transplacental
    Indication: Foetal Exposure During Pregnancy

Innohep 1000 (Tinzaparin Sodium) Solution FOR Injection, 10000iu / .5ml
    Dosage: 0.5 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Prograf
    Dosage: 2.5 g, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Pentasa
    Indication: Foetal Exposure During Pregnancy

Ursodiol
    Dosage: 200 mg, qid, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Calcium Carbonate
    Dosage: 1 df, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Prednisolone
    Indication: Foetal Exposure During Pregnancy



Possible Ursodiol side effects in female

Reported by a physician from France on 2012-04-06

Patient: female

Reactions: Dysmorphism

Drug(s) suspected as cause:
Innohep
    Dosage: reported as 10000iu, anti-xa/0.5ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2000-01-01
    End date: 2009-05-15

Calcium Carbonate
    Indication: Product Used FOR Unknown Indication

Ursodiol
    Dosage: 200 mh 4 times daily
    Indication: Product Used FOR Unknown Indication

Mycophenolate Mofetil (Cellcept)
    Dosage: therapy was stopped at 6 week of amenorrhea
    Indication: Liver Transplant

Aspegic 250
    Dosage: started before pregnancy. form powder for oral solution.
    Indication: Product Used FOR Unknown Indication

Prograf
    Dosage: started before pregnancy, frequency: daily
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Pentasa



Possible Ursodiol side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-05

Patient: female

Reactions: Congenital Nose Malformation, Maternal Drugs Affecting Foetus, Caesarean Section, Dysmorphism, Haematoma

Drug(s) suspected as cause:
Ursodiol
    Dosage: 200 mg, qid, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Calcium Carbonate
    Dosage: 1 df, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Innohep
    Dosage: 0.5 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Josacine / 00273602 / (Josamycin Propionate)
    Dosage: transplacental
    Indication: Foetal Exposure During Pregnancy

Pentasa
    Dosage: transplacental
    Indication: Foetal Exposure During Pregnancy

Prograf
    Dosage: 2.5 g, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Aspirin
    Dosage: 250 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy

Prednisolone
    Dosage: transplacental
    Indication: Foetal Exposure During Pregnancy

Cellcept
    Dosage: 250 mg, bid, transplacental
    Indication: Foetal Exposure During Pregnancy



Possible Ursodiol side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-02

Patient: female

Reactions: Dysmorphism

Drug(s) suspected as cause:
Calcium Carbonate
    Dosage: 1 df, daily
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Innohep
    Dosage: 0.5 ml, unknown/d
    Indication: Foetal Exposure During Pregnancy
    Start date: 2000-01-01
    End date: 2009-05-15

Aspegic 1000
    Dosage: 250 meq/ml, daily
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-01

Ursodiol
    Dosage: 200 mg, qid
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Prograf
    Dosage: 2.5 g , daily
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Mycophenolate Mofetil (Cellcept)
    Dosage: 500 mg, daily
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Josamycin; Pentasa

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017